Trisalus Life Sciences
Manufacturing · Colorado, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
6272 W 91st Ave, Westminster, Colorado, ...Phone Number
(888) 321-5212Website
www.trisaluslifesci.comRevenue
$44.9 MillionStock Symbol
TLSIIndustry
About Trisalus Life Sciences
TriSalus Life Sciences is dedicated to transforming outcomes for patients with solid tumors, specifically targeting liver and pancreatic tumors. The company integrates innovative delivery technology with standard-of-care therapies and investigational immunotherapy to overcome critical barriers such as intratumoral pressure and immunosuppression. Their therapeutic platform aims to enhance the efficacy of systemic immunotherapies, including checkpoint inhibitors. TriSalus is focused on clinical research to bring this potentially transformative treatment to patients.Explore more
Trisalus Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Trisalus Life Sciences
Compare insights from companies similar to Trisalus Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Trisalus Life Sciences
$44.9M
51-200
Public
$122.6M
2009
RH
Robert HolburnVice President, Chief Financial Officer
Trisalus Life Sciences Tech Stack
A closer look at the technologies used by Trisalus Life Sciences
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Trisalus Life Sciences
Sign Up For FreeTo access detailed company insights
TriSalus Life Sciences is dedicated to transforming outcomes for patients with solid tumors, specifically targeting liver and pancreatic tumors. The company integrates innovative delivery technology with standard-of-care therapies and investigational immunotherapy to overcome critical barriers such as intratumoral pressure and immunosuppression. Th... Read More
